Issue 10, 2019

Total synthesis of levetiracetam

Abstract

Total synthesis of levetiracetam, an active ingredient of epilepsy treatment medications, is reported. The reported method is based on a one-pot dehydration/sigmatropic rearrangement of (R,E)-hept-4-en-3-ol carbamate to the corresponding allylamine derivative, an advanced precursor of levetiracetam.

Graphical abstract: Total synthesis of levetiracetam

Supplementary files

Article information

Article type
Paper
Submitted
16 Jan 2019
Accepted
15 Feb 2019
First published
15 Feb 2019

Org. Biomol. Chem., 2019,17, 2770-2775

Total synthesis of levetiracetam

A. Narczyk, M. Mrozowicz and S. Stecko, Org. Biomol. Chem., 2019, 17, 2770 DOI: 10.1039/C9OB00111E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements